(Q42215003)

English

Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis

scientific article published on 3 June 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

Effect of virological response to entecavir on the development of hepatocellular carcinoma in hepatitis B viral cirrhotic patients: comparison between compensated and decompensated cirrhosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

0 references

liver cirrhosis

0 references

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24890440%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

author name string

Soon Sun Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24890440%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Jae Chul Hwang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24890440%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Seon Joo Ahn

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24890440%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Jae Youn Cheong

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24890440%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Sung Won Cho

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24890440%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

language of work or name

0 references

publication date

3 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

18 October 2017

The American Journal of Gastroenterology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24890440%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

109

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24890440%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24890440%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

1223-1233

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24890440%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Meta-analysis: the impact of oral anti-viral agents on the incidence of hepatocellular carcinoma in chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Virological response to entecavir is associated with a better clinical outcome in chronic hepatitis B patients with cirrhosis.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Management of hepatocellular carcinoma: An update

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Hepatocellular carcinoma in cirrhosis: incidence and risk factors

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Risk assessment for the development of hepatocellular carcinoma: according to on-treatment viral response during long-term lamivudine therapy in hepatitis B virus-related liver disease.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Virological response to entecavir reduces the risk of liver disease progression in nucleos(t)ide analogue-experienced HBV-infected patients with prior resistant mutants.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Integration of hepatitis B virus DNA into the genome of liver cells in chronic liver disease and hepatocellular carcinoma. Studies in percutaneous liver biopsies and post-mortem tissue specimens

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Genetic alterations associated with hepatocellular carcinomas define distinct pathways of hepatocarcinogenesis

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Clinical significance of serum type-III procollagen aminopropeptide in hepatitis B virus-related liver diseases

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Risk assessment of hepatitis B virus-related hepatocellular carcinoma development using liver stiffness measurement (FibroScan).

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Predictive scores for hepatocellular carcinoma development in chronic hepatitis B virus infection: "does one size fit all?".

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Independent risk factors and predictive score for the development of hepatocellular carcinoma in chronic hepatitis B

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2014.145

21 January 2018

Identifiers

10.1038/AJG.2014.145

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24890440%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24890440%20AND%20SRC:MED&resulttype=core&format=json

6 June 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42215003&oldid=1936179405"